JANSSEN CILAG S.P.A.
Summary
JANSSEN CILAG S.P.A. is registered in Italy and entered in the “Business Register (Registro delle Imprese)” under number 00962280590. Its legal form is Società Per Azioni (SPA) – joint-stock company (Italy). According to GLEIF, its ultimate parent is Johnson & Johnson (United States), which is also its direct parent. That group has 209 subsidiaries with LEIs in 47 countries, 3 of them in Italy. The LEI was first issued on 6 Feb 2019 and the record was last updated on 15 Jul 2026; the next renewal is due by 15 Aug 2027. GLEIF's ISIN mapping lists 1 ISIN for this LEI. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The ultimate-parent link rests on accounts for the period ending 2 Jan 2023, more than 24 months before this data release. The group may have changed since.
Company details
| Legal form | Società Per Azioni (SPA) joint-stock company (Italy) |
|---|---|
| Register | Business Register (Registro delle Imprese) · Register website |
| Registration number | 00962280590 |
| Registration authority | Infocamere |
| Jurisdiction | Italy |
| Registered address | VIALE FULVIO TESTI 280/6, 20126 MILANO, Italy |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 12 Feb 1981 |
| LEI | 54930026KRKVZGB0TB46 |
| LEI status | active |
| LEI first issued | 6 Feb 2019 |
| LEI record last updated | 15 Jul 2026 |
| Next LEI renewal | 15 Aug 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | Johnson & Johnson | Johnson & Johnson |
| Accounting period | 3 Jan 2022 to 2 Jan 2023 | 3 Jan 2022 to 2 Jan 2023 |
| Evidence | other official documents | other official documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Accounting standard | US GAAP | US GAAP |
| Relationship start | 5 Feb 2019 | 5 Feb 2019 |
| Recorded at GLEIF since | 26 Dec 2023 | 26 Dec 2023 |
| Last updated | 29 Jul 2025 | 29 Jul 2025 |
| Record status | current | current |
Other subsidiaries of the same direct parent (97)
- JOHNSON & JOHNSON MEDICAL S.P.A. Italy
- (強生(香港)有限公司) Hong Kong
- ACCLARENT, INC. United States
- ACTELION PHARMACEUTICALS US, INC. United States lapsed
- ACTELION TREASURY UNLIMITED COMPANY Ireland
- ALZA CORPORATION United States
- AMO HOLDINGS, INC. United States lapsed
- AMO SALES AND SERVICE, INC. United States
- AURIS HEALTH, INC. United States
- BEIJING DABAO COSMETICS CO., LTD. China lapsed
- BIOMEDICAL ENTERPRISES, INC. United States lapsed
- BIOSENSE WEBSTER, INC. United States
ISINs mapped to this LEI (1)
IT0000888641
1 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.